Page last updated: 2024-08-24

imiquimod and Anogenital Type Verrucous Carcinoma

imiquimod has been researched along with Anogenital Type Verrucous Carcinoma in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Agrawal, M; Gandhi, V; Sharma, P; Sonthalia, S	1
Marino, F	1
Hsu, CK; Lee, CN; Lee, JY	1
González-González, JG; González-Saldivar, G; Rodarte-Shade, M; Rodríguez-Gutiérrez, R	1
Gormley, RH; Kovarik, CL	1

Reviews

2 review(s) available for imiquimod and Anogenital Type Verrucous Carcinoma

Article	Year
Successful nonsurgical treatment of penile Buschke-Löwenstein tumor with 12 weeks of 5% imiquimod alone. International journal of STD & AIDS, 2019, Volume: 30, Issue:11 Topics: Adult; Antineoplastic Agents; Buschke-Lowenstein Tumor; Humans; Imiquimod; Interferon Inducers; Male; Ointments; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Treatment Outcome	2019
Human papillomavirus-related genital disease in the immunocompromised host: Part II. Journal of the American Academy of Dermatology, 2012, Volume: 66, Issue:6 Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts	2012

Article

Year

Successful nonsurgical treatment of penile Buschke-Löwenstein tumor with 12 weeks of 5% imiquimod alone.

International journal of STD & AIDS, 2019, Volume: 30, Issue:11

Topics: Adult; Antineoplastic Agents; Buschke-Lowenstein Tumor; Humans; Imiquimod; Interferon Inducers; Male; Ointments; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Treatment Outcome

2019

Human papillomavirus-related genital disease in the immunocompromised host: Part II.

Journal of the American Academy of Dermatology, 2012, Volume: 66, Issue:6

Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts

2012

Other Studies

3 other study(ies) available for imiquimod and Anogenital Type Verrucous Carcinoma

Article	Year
Complete healing of perianal giant condyloma (buschke-löwenstein tumor) with imiquimod 5% cream alone. Techniques in coloproctology, 2020, Volume: 24, Issue:12 Topics: Anus Neoplasms; Buschke-Lowenstein Tumor; Condylomata Acuminata; Humans; Imiquimod; Perineum	2020
Recalcitrant extragenital giant condyloma acuminatum: A need for combination therapy. Dermatologic therapy, 2019, Volume: 32, Issue:3 Topics: Adult; Axilla; Buschke-Lowenstein Tumor; Combined Modality Therapy; Cryotherapy; Humans; Imiquimod; Immunotherapy; Male; Podophyllotoxin; Skin Neoplasms; Treatment Outcome	2019
Buschke-Lowenstein tumor. The American journal of the medical sciences, 2015, Volume: 349, Issue:1 Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Buschke-Lowenstein Tumor; HIV Infections; Humans; Imiquimod; Male; Skin Neoplasms	2015